AstraZenaca last week settled with the Department of Justice over allegedly offering kickbacks to Medco Health Solutions, a pharmacy benefits manager, in exchange for Medco maintaining AstraZeneca’s drug Nexium in favorable status on its formulary. AstraZeneca settled the allegations for $7.9 million. - See more at: http://www.policymed.com/2015/02/astrazeneca-pays-79-million-to-resolve-kickback-allegations-related-to-pbm-formulary-placement.html#sthash.NIGg4bUk.dpuf